This work is licensed under the Creative Commons Attribution 4.0 International License.
Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J 2015; 46:903.GalièNHumbertMVachieryJL2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)20154690310.1183/13993003.01032-201526318161Search in Google Scholar
T. F. Feltes et al., “Indications for cardiac catheterization and intervention in pediatric cardiac disease: A scientific statement from the American Heart Association,” Circulation, vol. 123, no. 22, pp. 2607–2652, 2011, doi: 10.1161/CIR.0b013e31821b1f10.FeltesT. F.“Indications for cardiac catheterization and intervention in pediatric cardiac disease: A scientific statement from the American Heart Association,”1232226072652201110.1161/CIR.0b013e31821b1f1021536996Open DOISearch in Google Scholar
M. J. del Cerro et al., “Cardiac catheterization in children with pulmonary hypertensive vascular disease: Consensus statement from the Pulmonary Vascular Research Institute, Pediatric and Congenital Heart Disease Task Forces,” Pulm. Circ., vol. 6, no. 1, pp. 118–125, 2016, doi: 10.1086/685102.del CerroM. J.“Cardiac catheterization in children with pulmonary hypertensive vascular disease: Consensus statement from the Pulmonary Vascular Research Institute, Pediatric and Congenital Heart Disease Task Forces,”61118125201610.1086/685102480966727076908Open DOISearch in Google Scholar
Y. Wang, S. Chen, and J. Du, “Bosentan for Treatment of Pediatric Idiopathic Pulmonary Arterial Hypertension: State-of-the-Art,” Front. Pediatr., vol. 7, no. July, pp. 1–10, 2019, doi: 10.3389/fped.2019.00302.WangY.ChenS.DuJ.“Bosentan for Treatment of Pediatric Idiopathic Pulmonary Arterial Hypertension: State-of-the-Art,”7July110201910.3389/fped.2019.00302666396731396496Open DOISearch in Google Scholar
Rosenzweig EB, Abman SH, Adatia I, et al. Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management. Eur Respir J 2019; 53.RosenzweigEBAbmanSHAdatiaIPaediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management20195310.1183/13993003.01916-2018635133530545978Search in Google Scholar
R. L. E. van Loon et al., “Outcome of Pediatric Patients With Pulmonary Arterial Hypertension in the Era of New Medical Therapies,” Am. J. Cardiol., vol. 106, no. 1, pp. 117–124, 2010, doi: 10.1016/j.amjcard.2010.02.023.van LoonR. L. E.“Outcome of Pediatric Patients With Pulmonary Arterial Hypertension in the Era of New Medical Therapies,”1061117124201010.1016/j.amjcard.2010.02.02320609658Open DOISearch in Google Scholar
Miklashevich I.M., Shkolnikova M.A., Gorbachevsky S.V., Shmalts A.A., Groznova O.S., Sadykova D.I., Yakovleva L.V., Degtyarev D.N., Burov A.A., Ovsyannikov D.Yu., Volkov A.V. CONTEMPORARY STRATEGY OF PULMONARY HYPERTENSION MANAGEMENT IN PEDIATRICS. Cardiovascular Therapy and Prevention. 2018;17(2):101–124. (In Russ.) https://doi.org/10.15829/1728-8800-2018-2-101-124MiklashevichI.M.ShkolnikovaM.A.GorbachevskyS.V.ShmaltsA.A.GroznovaO.S.SadykovaD.I.YakovlevaL.V.DegtyarevD.N.BurovA.A.OvsyannikovD.Yu.VolkovA.V.CONTEMPORARY STRATEGY OF PULMONARY HYPERTENSION MANAGEMENT IN PEDIATRICS2018172101124(In Russ.) https://doi.org/10.15829/1728-8800-2018-2-101-12410.15829/1728-8800-2018-2-101-124Search in Google Scholar
Avitabile, C.M., Vorhies, E.E. & Ivy, D.D. Drug Treatment of Pulmonary Hypertension in Children. Pediatr Drugs 22, 123–147 (2020).AvitabileC.M.VorhiesE.E.IvyD.D.Drug Treatment of Pulmonary Hypertension in Children22123147202010.1007/s40272-019-00374-2708845631960361Search in Google Scholar